Clinical Trial Update: PT-MSCs Exosome Injection in the Treatment of Chronic-to-acute Liver Failure [EARLY_Phase 1]

View source ↗

Summary

Early-phase Phase 1 clinical trial update on PT-MSCs Exosome Injection for Acute-on-Chronic Liver Failure; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• On Chronic Liver Failure

Drugs mentioned

• PT-MSCs Exosome Injection (mesenchymal stem cell-derived exosomes)

Snippet

Sponsor: Third Affiliated Hospital, Sun Yat-Sen University | Conditions: Acute-on-Chronic Liver Failure (ACLF) | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING